ÂÜÀòÂÒÂ×

Dr. Michael W. Hofmann serves as the Senior Medical Scientific Affairs Manager at HENNIG ARZNEIMITTEL GmbH & Co. KG, focusing on Lunivia® and Arlevert® while managing the non-interventional study SOMNIA. Previous roles include Consultant and Freelance Interim Manager at Hofmann Life Science Consulting, Medical Manager for Rheumatology at Chugai Pharma Germany, and co-founder of Mannheim Pharma & Diagnostics GmbH and X2-Pharma GmbH. Notable achievements include leading drug discovery initiatives at Axiogenesis and Alantos Pharmaceuticals, where Dr. Hofmann directed preclinical research and development. Educational qualifications include a Doctorate in Molecular Cell Biology and a Graduate degree in Biochemistry and Genetics from Heidelberg University.